EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitis

Swagata Konwar, Sophie Schroda, Manuel Rogg, Jessika Kleindienst, Eva L Decker, Martin Pohl, Barbara Zieger, Jens Panse, Hong Wang, Robert Grosse, Christoph Schell, Sabine Vidal und 4 weitere

Journal of Clinical Investigation · 01.07.2025 · 135 (13)

DOI: 10.1172/jci180062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 08.05.2025. Verfasst von Swagata Konwar und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine IV (Nephrology), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Thrombospondin 1, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Complement Pathway, Alternative. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Complement activation is a relevant driver in the pathomechanisms of vasculitis. The involved proteins in the interaction between endothelia, complement, and platelets in these conditions are only partially understood. Thrombospondin-1 (TSP-1), found in platelet α-granules and released from activated endothelial cells, interacts with factor H (FH) and vWF. However, to our knowledge, direct regulatory interaction with the complement cascade has not yet been described. Our study shows that TSP-1 is a potent, FH-independent inhibitor of the alternative complement pathway. TSP-1 binds to complement proteins and inhibits cleavage of C3 and C5 and the formation of the membrane attack complex. We validated complement-regulatory function in blood samples from patients with primary complement defects. The physiological relevance of TSP-1 was demonstrated in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) by significantly enhanced TSP-1 staining in glomerular lesions and increased complement activity and NETosis after TSP-1 deficiency in an in vitro and in vivo model of AAV. The complement-inhibiting function of TSP-1 represents an important mechanism in the interaction of endothelia and complement. In particular, the interplay between released TSP-1 and the complement system locally, especially on surfaces, influences the balance between complement activation and inhibition and may be relevant in various vascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thrombospondin 1Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisComplement Pathway, AlternativeHumansAnimalsMiceFemaleMaleComplement C5Complement C3Mice, KnockoutMiddle AgedComplement Factor H

Stichwörter der Autor:innen

ComplementEndothelial cellsImmunologyInflammationVascular biologyVasculitis

Substanzen

Thrombospondin 1thrombospondin-1, humanComplement C5Complement C3Complement Factor H

Autor:innen und Institutionen

  • Department of Internal Medicine IV (Nephrology), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Department of General Pediatrics, Adolescent Medicine and Neonatology, Faculty of Medicine, and.
  • Institute of Surgical Pathology, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
  • Plant Biotechnology, Faculty of Biology, University of Freiburg, Freiburg, Germany.
  • Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg, Germany.
  • Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany.

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Konwar, S., Schroda, S., Rogg, M., Kleindienst, J., Decker, E. L., Pohl, M., Zieger, B., Panse, J., Wang, H., Grosse, R., Schell, C., Vidal, S., Liu, X., Gorzelanny, C., Tschongov, T., & Häffner, K. (2025). Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitis. Journal of Clinical Investigation, 135(13). https://doi.org/10.1172/jci180062

Vancouver

Konwar S, Schroda S, Rogg M, Kleindienst J, Decker EL, Pohl M, et al. Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitis. Journal of Clinical Investigation. 2025;135(13). doi:10.1172/jci180062

BibTeX
@article{Konwar2025,
  author = {Konwar, Swagata and Schroda, Sophie and Rogg, Manuel and Kleindienst, Jessika and Decker, Eva L and Pohl, Martin and Zieger, Barbara and Panse, Jens and Wang, Hong and Grosse, Robert and Schell, Christoph and Vidal, Sabine and Liu, Xiaobo and Gorzelanny, Christian and Tschongov, Todor and Häffner, Karsten},
  title = {Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitis},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {13},
  doi = {10.1172/jci180062}
}
Kostenlos starten →